The transactions involved the disposition of 30,000 shares on July 16, 2026, with a total valuation of ~$2.5 million.
The dispositions were executed from indirect holdings and included 20,000 shares sold by a spouse and 10,000 shares gifted to the Scott Family Fund.
The move occurred as the stock achieved a 470% one-year return as of the July 16, 2026 transaction date.
Geoffrey Gates Scott, a Director at Aehr Test Systems, Inc. (NASDAQ:AEHR), reported the disposition of 30,000 shares of common stock on July 16, 2026. SEC Form 4 filing
| Metric | Value |
|---|---|
| Transaction value | $2.5 million |
| Shares sold (indirectly held) | 30,000 |
| Post-transaction shares (directly held) | 54,522 |
| Post-transaction shares (indirectly held) | 60,686 |
| Post-transaction value | $9.70 million |
Transaction value based on SEC Form 4 weighted average sale price ($82.13); post-transaction value based on July 16, 2026 market close ($84.20).
| Metric | Value |
|---|---|
| Share Price (as of market close 2026-07-16) | $84.20 |
| Market Capitalization | $2.5 billion |
| Revenue (TTM) | $50.9 million |
| Net Income (TTM) | -$7.1 million |
Aehr Test Systems, founded in 1977 and headquartered in Fremont, California, is a specialized provider of semiconductor test and burn-in equipment with a market cap of $2.5 billion. The company has demonstrated significant market momentum, with share price appreciation of 469.69% over the past twelve months, reflecting growing demand for advanced semiconductor testing solutions.
With 136 employees and trailing 12-month revenues of $50.9 million, Aehr operates in the capital-intensive semiconductor equipment sector, positioning itself as a niche player serving critical validation requirements in the semiconductor manufacturing ecosystem.
The July 16 sale of Aehr Test Systems stock did not involve a disposition by Board of Directors member Geoffrey Scott. Rather, his spouse sold 20,000 shares. Another 10,000 shares were gifted to the Scott Family Fund.
Scott’s spouse holds 30,000 shares after the sale, which means the disposition reduced holdings by a substantial 40%. This is a significant reduction, and came after shares soared 470% over the past 12 months.
That said, the stock price has gone up since this sale, exceeding $100 per share as of August 4. Aehr Test Systems stock rose due to strong performance in its fiscal fourth quarter ended May 29. Revenue reached $18.8 million, compared to $14.1 million in the previous year. Sales are up as a result of increased demand from semiconductor chip manufacturers amid the rise of artificial intelligence.
Geoffrey Scott retains over 54,000 shares after the July 16 transaction, with some of these comprising unvested restricted stock units (RSUs). The RSUs will have to vest before they are eligible to be sold, ensuring continued alignment with shareholder interests.
Before you buy stock in Aehr Test Systems, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Aehr Test Systems wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $395,463!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,268,290!*
Now, it’s worth noting Stock Advisor’s total average return is 927% — a market-crushing outperformance compared to 211% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
See the 10 stocks »
*Stock Advisor returns as of August 4, 2026.
Robert Izquierdo has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.